Page last updated: 2024-12-08
phenylalanyl adenylate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
phenylalanyl adenylate: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 193730 |
| SCHEMBL ID | 4945718 |
| MeSH ID | M0087249 |
Synonyms (14)
| Synonym |
|---|
| adenosine-5'-[phenylalaninyl-phosphate] |
| FA5 , |
| phenylalanyl adenylate |
| 35874-27-2 |
| [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] (2s)-2-amino-3-phenylpropanoate |
| l-phenylalanine, monoanhydride with 5'-adenylic acid |
| phe-pa |
| SCHEMBL4945718 |
| 5'-o-[(s)-{[(2s)-2-amino-3-phenylpropanoyl]oxy}(hydroxy)phosphoryl]adenosine |
| Q27460192 |
| (s)-2-amino-3-phenylpropanoic (((2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphoric) anhydride |
| 9-(5-o-{[(2-amino-3-phenylpropanoyl)oxy](hydroxy)phosphoryl}pentofuranosyl)-9h-purin-6-amine |
| DTXSID10957293 |
| AKOS040753524 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.09
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.09) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||